Amended agreement with Ginkgo Bioworks to accelerate commercialization of cultured cannabinoids
Announced strategic investment in PharmaCann, a leading U.S. cannabis company
Spinach launched new products in the edible, concentrate, and flower categories in Canada
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), today announces its 2021 Second Quarter business results.
“This quarter, Cronos Group continued to bring high-quality and insight-driven products to market. I am particularly proud of the Spinach brand gummy innovation launched this quarter into the Canadian adult-use market, SOURZ by Spinach, which has quickly jumped to be one of the most desirable products in the edibles category. In the U.S., we officially re-launched PEACE+ in the direct-to-consumer channel, which rounds out our different pricing tiers for the U.S. hemp-derived CBD market. Having brands across price points and usage occasions is critical to meeting consumer needs in the CBD category,” said Kurt Schmidt, President and CEO, Cronos Group.
“Our U.S. growth strategy focuses on delivering long-term shareholder value by assembling a best-in-class brand and intellectual property portfolio and positioning to deploy our products in the U.S. market through investments and opportunities with companies that share our vision and commitment to responsibly distributing disruptive cannabinoid products that improve people’s lives. In the second quarter of 2021, we were able...
Read Full Story: https://investingnews.com/news/cannabis-investing/cronos-group-reports-2021-second-quarter-results/
Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.